Health News Archive - June 07, 2010

LEUVEN, Belgium, June 7, 2010 /PRNewswire-FirstCall/ -- - Data Presented Show Microplasmin Cures Approximately 50% of Patients With Macular Hole ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr.

BARCELONA, Spain and RESEARCH TRIANGLE PARK, N.C., June 7 /PRNewswire-FirstCall/ -- Grifols (GRF.MC) a global healthcare company and leading producer of plasma protein therapies, and Talecris (Nasdaq: TLCR) a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.

LONDON, June 7, 2010 /PRNewswire-FirstCall/ -- - Ground-Breaking Partnership Extends the Breadth of Processing Capabilities in Misys Summit FT Misys plc (LSE: MSY), the global application software and services company, today announces that it has partnered with SmartStream Technologies to deliver improved risk control and greater efficiency across the entire trade transaction lifecycle. The partnership brings together two leading software providers to deliver a range of solutions that provide broad connectivity to market participants and exchanges, improve processing efficiencies and reduce operational risk throughout the transaction lifecycle. SmartStream's market-leading reconciliation software will be embedded into Misys Summit FT and Opics Plus to provide additional transaction matching, exceptions and investigations management to Misys' award-winning solutions.

LONDON, June 7, 2010 /PRNewswire/ -- Several key themes about change and customer-centricity emerged at this year's eyeforpharma's SFE 2010 conference in Barcelona, April 27-29th. To view the Multimedia News release, please click here: http://multivu.prnewswire.com/mnr/prne/eyeforpharma/42433/ Tyrone Edward's (Senior VP, Merck ret.) covers the key conference themes with his keynote "Boost your sales productivity in today's challenging pharmaceutical market".

OAKLAND, Calif., June 7 /PRNewswire/ -- Kaiser Permanente is the first health and hospital system to earn a perfect 100 percent rating on the Healthcare Equality Index.

TEL AVIV, Israel, June 7, 2010 /PRNewswire-FirstCall/ -- BSP Biological Signal Processing Ltd. (http://www.bsp.co.il), develops and markets innovative systems for non-invasive diagnosis and monitoring of Ischemic Heart Disease (IHD) based on its proprietary HyperQ(TM) technology.

FREISING-WEIHENSTEPHAN, Germany, June 7, 2010 /PRNewswire/ -- Pieris AG announced today that Laurent Audoly, Ph.D., has joined the company as Chief Scientific Officer, effective immediately. Dr. Audoly, most recently Biologics Research Site Lead at Merck & Co.

DALLAS, Texas, June 7, 2010 /PRNewswire/ -- ReportsandReports Announce it Will Carry the Commercial Insight Osteoporosis Market Players Maximize Revenue Growth Before the Next Challenging Phase Market Research Report ( http://www.reportsandreports.com/Report/24113/) in its Store. Browse the complete Report on: http://www.reportsandreports.com/market-reports/commercial-insight-osteoporos is-market-players-maximize-revenu/ (Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field.

STRATFORD-UPON-AVON, England, June 7, 2010 /PRNewswire/ -- - On World Heart Rhythm Week, Arrhythmia Alliance Launches 'Know Your Pulse' Campaign to Raise Awareness of the Importance of Pulse Checking to Keep Cardiac Conditions Under Control Arrhythmia Alliance, the Heart Rhythm Charity, announced today the results of a survey conducted in Europe that showed a large number of respondents ignore basic measures to check for potential cardiac arrhythmias, or heart rhythm disorders.